News

Article

Pharmaceutical Technology

Pharmaceutical Technology-10-02-2002
Volume26
Issue 10

Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

Author(s):

Jim Miller

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

External Link - article-36193.pdf

Articles in this issue
FDA Launches Major Review of CGMPs
Understanding Pharmaceutical Flows
Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook
An Overview of the Validation Approach for Moist Heat Sterilization, Part II
Cyclodextrins as Sustained-Release Carriers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 12th 2025

Nxera’s New GLP-1 and GPCR-Targeted Drug Programs Aim to Advance Obesity and Metabolic Disorder Therapies

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 12th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Skin diseases concept. macro skin of human hand.Medicine and dermatology concept. Details of human skin background. | Image Credit: © daily_creativity - stock.adobe.com
August 12th 2025

Almirall Selects 2nd Dermatology Target in AI Drug Discovery Collaboration with Absci

Patrick Lavery
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
August 12th 2025

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

GLP-1 and obesity related newspaper headlines | Image Credit: © zimmywts - stock.adobe.com
August 12th 2025

Lilly’s Oral GLP-1 Candidate Demonstrates 27-Pound Average Weight Loss in Phase III Trial

Patrick Lavery
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 12th 2025

Bora Pharmaceuticals to Expand Midwest Manufacturing Site

Susan Haigney